The prognostic significance of CD11b+CX3CR1+ monocytes in patients with newly diagnosed diffuse large B-cell lymphoma
Open Access
- 23 September 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (54) , 92289-92299
Abstract
The prognostic significance of CD11b + CX3CR1 + monocytes in patients with newly diagnosed diffuse large B-cell lymphoma The prognostic significance of CD11b+CX3CR1+ monocytes in patients with newly diagnosed diffuse large B-cell lymphomaKeywords
This publication has 27 references indexed in Scilit:
- Treatment of Diffuse Large B Cell LymphomaThe Korean Journal of Internal Medicine, 2012
- The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphomaLeukemia, 2011
- IL-10 Immunomodulation of Myeloid Cells Regulates a Murine Model of Ovarian CancerFrontiers in Immunology, 2011
- WHO Classification of Malignant Lymphomas in Korea: Report of the Third Nationwide StudyThe Korean Journal of Pathology, 2011
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxisBlood, 2008
- The chemokine system in arteriogenesis and hind limb ischemiaJournal of Vascular Surgery, 2007
- Revised Response Criteria for Malignant LymphomaJournal of Clinical Oncology, 2007
- Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarrayBlood, 2004
- A new class of membrane-bound chemokine with a CX3C motifNature, 1997